Medical news of Remedium.ru portal is the most update information on pharmaceutical and medical equipment market

Journals

REMEDIUM

The periodical about the pharmaceutical and medical equipment markets

ROSSIYSKIE APTEKI

(Russian pharmacies) - specialized periodical edition for pgarmacy professionals

MEDITSINSKY SOVET

Medical Council - Scientific Journal for Physicians


Home

News

Russia’s leading biotech firm Biocad has analyzed results from its Phase II study in which the original Russian interleukin (IL)-17 inhibitor proved highly effective in long-term therapy in patients with severe psoriasis. The drug also showed positive results in the treatment of ankylosing spondylitis.
Western pharmaceutical companies do not plan to reduce their presence in the Russian market due to a recent deterioration of business climate in the country, caused by a new package of Western sanctions, according to the companies and the Russian Ministry of Health.
UK pharma major GlaxoSmithKline (LSE: GSK) plans to become a leading supplier of anti-HIV drugs for state needs in Russia, according to sources in the Russian Ministry of Health.
Russian regulators have approved the Russian company BIOCAD’s infliximab biosimilar as a treatment for rheumatoid arthritis and ankylosing spondylitis.
Russian millionaire Viktor Kharitonin has consolidated the 100% stake in Pharmstandard, one of Russia’s largest drugmakers and one of the largest suppliers of drugs for state purchases, according to the company
News 11 - 15 из 958
Начало | Пред. | 1 2 3 4 5 | След. | КонецВсе

Remedium group

REMEDIUM

publishing house

CLIFAR

programmer of electronic software products

R-PRESS

advertisement agency

REPRENT

rent-a-rep company